We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas
Price data last checked 102 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B00E4WZS0C
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 24 July 2013
Similar Products You Might Like
98% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Oceana
£325.00
12 Jan 2026
98% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Asia
£325.00
12 Jan 2026
98% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe
£325.00
13 Jan 2026
98% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Africa
£325.00
02 Feb 2026
98% match
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Middle East
£325.00
07 Jan 2026
96% match
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
£325.00
31 Mar 2026
96% match
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
£325.00
26 Mar 2026
95% match
The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean
£325.00
28 Jan 2026
95% match
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Asia
£325.00
10 Mar 2026
95% match
The 2013-2018 Outlook for Drugs in India
£495.00
16 Dec 2025
95% match
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
£325.00
20 Apr 2026
95% match
The 2013-2018 Outlook for Allergy Drugs in North America & the Caribbean
£325.00
11 Jan 2026
95% match
The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean
£325.00
28 Jan 2026
95% match
The 2013-2018 Outlook for Neurostimulation Devices in North America & the Caribbean
£325.00
26 Jan 2026
95% match
The 2013-2018 Outlook for Irritable Bowel Syndrome (IBS) Therapeutics in the United States
£495.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean
£325.00
21 Jan 2026
95% match
The 2013-2018 Outlook for Therapeutic Apheresis Products in The Americas
£325.00
09 Jan 2026
95% match
The 2013-2018 Outlook for Allergy Drugs in Latin America
£325.00
11 Jan 2026
95% match
The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Latin America
£325.00
30 Jan 2026
95% match
The 2013-2018 Outlook for Allergy Drugs in Asia
£325.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Allergy Drugs in Africa, Europe & the Middle East
£325.00
12 Jan 2026
95% match
The 2013-2018 Outlook for Application Acceleration Products in The Americas
£325.00
01 Feb 2026
94% match
The 2013-2018 Outlook for E-Prescription Systems in North America & the Caribbean
£325.00
17 Feb 2026
94% match
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
£495.00
08 Jan 2026